Back to CRVS
Western Pacific Wealth Management, LP → CRVS
Western Pacific Wealth Management, LP CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$23K
Q3 2026
Peak value
$30K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $15K |
| Q4 2025 | $15K |
| Q1 2026 | $29K |
| Q2 2026 | $30K |
| Q3 2026 | $23K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $23K | 2.0K | — | — |
| Q2 2026 | $30K | 2.0K | — | — |
| Q1 2026 | $29K | 2.0K | — | — |
| Q4 2025 | $15K | 2.0K | — | — |
| Q3 2025 | $15K | 2.0K | — | — |
Other funds holding CRVS
Other Western Pacific Wealth Management, LP positions
BX
$12.9MVANGUARD DIVIDEND APPRECIATION ETF
BX
$12.8MVANGUARD DIVIDEND APPRECIATION ETF
VGES
$11.9MVANGUARD HIGH DIVIDEND YIELD INDEX ETF
BX
$11.8MVANGUARD DIVIDEND APPRECIATION ETF
VGES
$11.7MVANGUARD HIGH DIVIDEND YIELD INDEX ETF
BX
$11.5MVANGUARD DIVIDEND APPRECIATION ETF
VGES
$11MVANGUARD HIGH DIVIDEND YIELD INDEX ETF
BX
$10.7MVANGUARD DIVIDEND APPRECIATION ETF